Adult
Pediatric
Newly Diagnosed Before Treatment
In Treatment In Treatment
After Treatment After Treatment
Blood CancersBreast CancerCancer Genetics and Prevention Cutaneous (Skin) CancerGastrointestinal CancerGenitourinary CancerGynecological CancerHead and Neck CancerHematologyMelanomaNeuro-OncologySarcomaStem Cell TransplantThoracic Cancer
Pediatric Cancers
Regorafenib was found to reduce the risk of disease progression or death by more than 70 percent in patients whose tumors had become resistant to Gleevec and Sutent.
Researchers at Dana-Farber/Children's Hospital Cancer Center have devised a strategy to directly activate a natural "death" protein, triggering the self-destruction of cells — which could lead to new possibilities for designing cancer drugs.
Dana-Farber researchers report a novel compound has become the first targeted therapy to benefit patients with non-small cell lung cancer.
Researchers at Dana-Farber/Children's Hospital Cancer Center have created a peptide that overcomes drug resistance and reactivates programmed cell death in recurrent blood cancers.
Dr. Ann Partridge discusses new efforts for improved survivorship care. Catherine Fitch, a former Dana-Farber patient, provides insight into the challenges she has faced in the 36 years since surviving Hodgkin's lymphoma.
A study led by Dr. Mary Ellen Taplin that looked at small group of men with prostate cancer showed that treatment with Zytiga eliminated or greatly reduced the size of prostate tumors in one-third of patients treated for six months before surgery.
Patriots players Devin McCourty and Julian Edelman visited patients and signed autographs at the Kraft Family Blood Donor Center at Dana-Farber as part of the Patriots Charitable Foundation’s Celebrate Volunteerism campaign.
Dr. Glenn Dranoff talks about the new era of immune therapies being recognized as an important component of cancer treatment.
June 05, 2012
12:00 AM - 12:00 AM
City Hall Plaza, Boston
Please join us for the 30th annual all-you-can-eat ice cream festival at Boston City Hall Plaza. The event runs from noon to 8:00 p.m. more
Burger King - A Chance for Kids®
Participating Restaurants
Burger King - A Chance for Kids® more
Stop & Shop Triple Winner Program
April 13 through July 12, Stop & Shop customers have the opportunity to help support pediatric brain tumor care and research at Dana-Farber Cancer Institute through Stop & Shop's annual Triple Winner Game®. Customers who give a $1 contribution to the Jimmy Fund receive a Triple Winner Game card and receive free store products, coupons, gift cards, or cash prizes up to $10,000.
Thriving with Yoga
4:30 PM - 5:30 PM
Elliott Regional Cancer Center 40 Buttrick Rd Londonderry NH
A free program in partnership with YogaCaps, Inc. Open to beginners and those experienced with yoga with a current or past cancer diagnosis. Please call 603-670-0302 to register. more
Patient referral information, clinical resources and more.
For adults:877-442-3324 (877-442-DFCI)For children:888-733-4662 (888-PEDI-ONC)Or complete the online form.
Search current cancer clinical trials at Dana-Farber.
There are many ways to support Dana-Farber and the Jimmy Fund.
More ways to helpGiving Catalog
Insight features the latest in cancer care and research news from Dana-Farber.Read the blog